MedTrace Logo

Measurement of Substance P in Saliva of Low Back Pain Patients

NCT00735735 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-08-28

No results posted yet for this study

Summary

The purpose of this study is to compare the levels of Substance P in saliva, in patients with severe chronic low back pain and in subjects without it. In addition, to explore a possible cutoff point, in order to define normal and pathological levels of Substance P in saliva. The ultimate objective would be to design a measurement method for use in routine clinical practice.

Conditions

  • Low Back Pain

Interventions

OTHER

The taking of a saliva sample from each subject.

After taking the sample, the saliva will be transferred via a pipette to a clean tube which will be labeled with the subject's name, the date and the hour. Once a month the tubes will be sent to the collaborating laboratory for analysis.

Sponsors & Collaborators

  • Kovacs Foundation

    lead OTHER

Principal Investigators

  • Francisco M Kovacs, MD, PhD · Kovacs Foundation, Palma de Mallorca, 07012, Spain

  • Mario Gestoso, MD · Kovacs Foundation,Palma de Mallorca, Spain

Study Design

Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-01-31
Completion
2014-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735735 on ClinicalTrials.gov